Equity Profile

IDXX

IDEXX LABS INC

Health CareHealth Care Equipment$44.3B

May5Tue

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:30 AM EDT

IDEXX Laboratories Beats on EPS, Stock Down 0.03%

Metric	Actual	Expected	Surprise
EPS	$3.47	$3.41	+1.49%
Revenue	N/A	$1.1B	N/A

management commentary, guidance changes, and full analysis available with Pro.

IDEXX Laboratories Beats on EPS, Stock Down 0.03%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$3.47	$3.41	+1.49%
Revenue	N/A	$1.1B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

IDEXX Laboratories reported better-than-expected earnings per share, but revenue figures were not disclosed. The stock reacted slightly down by 0.03%, indicating that investors may have been looking for more comprehensive results or guidance. The lack of revenue data and management commentary could leave some investors uncertain about the company's future performance.

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of veterinary diagnostic products and services, primarily focused on animal health....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and overall financial health.

$3.41

Revenue

Total revenue reflects the company's sales performance and market demand for its products.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of veterinary diagnostic products and services, primarily focused on animal health. As part of the Health Care sector, IDEXX plays a crucial role in enhancing pet care through innovative testing solutions, which are increasingly important as pet ownership rises and owners seek better health management for their animals.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

In Q4-2025, IDEXX reported an EPS of $2.92, slightly missing the estimate of $2.93, which led to a stock decline of 4.60% the following day. The company continues to navigate a competitive landscape while focusing on innovation.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IDEXX to report strong earnings this quarter, with a consensus EPS of $3.41. The company has a solid track record of beating earnings estimates, which could lead to positive market reactions.

Bull Case

If IDEXX exceeds expectations, it could signal strong demand for its products and services, leading to a potential stock price increase.

Bear Case

Conversely, if the company fails to meet earnings expectations, it may indicate underlying issues in sales or market competition, resulting in a negative reaction from investors.

Key Metrics to Watch

EPS

$3.41

Earnings per share is a key indicator of the company's profitability and overall financial health.

Revenue

$1.1B

Total revenue reflects the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $3.41?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What insights can management provide on revenue growth and demand trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to capitalize on the growing pet care market, particularly in diagnostics.

Supporting Evidence

IDEXX has historically beaten earnings estimates 75% of the time, indicating potential for positive surprises.

The recent decline in stock price following a small EPS miss may have created a buying opportunity for investors.

Options pricing suggests a significant move, indicating that traders are anticipating volatility that could favor a positive outcome.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it follows a mixed earnings history, with recent trends showing both strong beats and misses.

Bull Confirmed If

Earnings exceeding $3.41 with revenue growth indicating strong demand.

Bear Confirmed If

Earnings falling below $3.35, suggesting potential weaknesses in sales.

Pre-Earnings Positioning

Options Market

Implied Move

±10.2%

Historical Avg

±10.0%

In line with history

The options market is pricing in a significant move around the earnings announcement, suggesting that traders expect volatility.

Options are pricing ±10.7% while IDXX has averaged ±10.0% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.7%

30d HV

28.6%

Calls (19K)P/C Ratio: 0.75Puts (14K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests a potential stock increase of around 7.94%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess management's commentary.

Miss

A miss could lead to a decline in stock price, with historical data suggesting an average drop of 0.73%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic technology.
2Management's outlook on the veterinary market and demand trends for IDEXX's products.
3Insights into cost management and operational efficiency improvements.
4Comments on competitive pressures and how IDEXX plans to address them.
5Any guidance on future revenue growth expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of veterinary diagnostic products and services, primarily focused on animal health....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and overall financial health.

$3.41

Revenue

Total revenue reflects the company's sales performance and market demand for its products.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If IDEXX exceeds expectations, it could signal strong demand for its products and services, leading to a potential stock price increase.

Bear Case

Conversely, if the company fails to meet earnings expectations, it may indicate underlying issues in sales or market competition, resulting in a negative reaction from investors.

Key Metrics to Watch

EPS

$3.41

Earnings per share is a key indicator of the company's profitability and overall financial health.

Revenue

$1.1B

Total revenue reflects the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $3.41?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What insights can management provide on revenue growth and demand trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to capitalize on the growing pet care market, particularly in diagnostics.

Supporting Evidence

IDEXX has historically beaten earnings estimates 75% of the time, indicating potential for positive surprises.

The recent decline in stock price following a small EPS miss may have created a buying opportunity for investors.

Options pricing suggests a significant move, indicating that traders are anticipating volatility that could favor a positive outcome.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it follows a mixed earnings history, with recent trends showing both strong beats and misses.

Bull Confirmed If

Earnings exceeding $3.41 with revenue growth indicating strong demand.

Bear Confirmed If

Earnings falling below $3.35, suggesting potential weaknesses in sales.

Pre-Earnings Positioning

Options Market

Implied Move

±10.2%

Historical Avg

±10.0%

In line with history

The options market is pricing in a significant move around the earnings announcement, suggesting that traders expect volatility.

Options are pricing ±10.7% while IDXX has averaged ±10.0% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.7%

30d HV

28.6%

Calls (19K)P/C Ratio: 0.75Puts (14K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests a potential stock increase of around 7.94%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess management's commentary.

Miss

A miss could lead to a decline in stock price, with historical data suggesting an average drop of 0.73%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic technology.
2Management's outlook on the veterinary market and demand trends for IDEXX's products.
3Insights into cost management and operational efficiency improvements.
4Comments on competitive pressures and how IDEXX plans to address them.
5Any guidance on future revenue growth expectations.